<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>MRC Centre for Inflammation Research</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D6142A77-0EAB-46B6-BA55-A4B63D1CE79C"><gtr:id>D6142A77-0EAB-46B6-BA55-A4B63D1CE79C</gtr:id><gtr:firstName>Neil</gtr:firstName><gtr:surname>Williams</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/76FF9A66-00E9-436E-86E8-CBE1D289D48A"><gtr:id>76FF9A66-00E9-436E-86E8-CBE1D289D48A</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Longbottom</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1203F34E-033E-4A0D-B22C-EFC7DE8D026A"><gtr:id>1203F34E-033E-4A0D-B22C-EFC7DE8D026A</gtr:id><gtr:firstName>Gary</gtr:firstName><gtr:surname>Entrican</gtr:surname><gtr:orcidId>0000-0002-8822-2331</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/62052C95-B3EC-4B43-97F5-8AE7A4A466D8"><gtr:id>62052C95-B3EC-4B43-97F5-8AE7A4A466D8</gtr:id><gtr:firstName>Jayshree</gtr:firstName><gtr:surname>Dave</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A58411EA-04FC-49BC-B7D9-69AB715F66D6"><gtr:id>A58411EA-04FC-49BC-B7D9-69AB715F66D6</gtr:id><gtr:firstName>G</gtr:firstName><gtr:surname>Scott</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/867F68C5-58E9-4623-8552-5AEA707EF03D"><gtr:id>867F68C5-58E9-4623-8552-5AEA707EF03D</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:surname>Clarke</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/10CCD6E3-9640-4290-8A2E-B6948B428BC4"><gtr:id>10CCD6E3-9640-4290-8A2E-B6948B428BC4</gtr:id><gtr:firstName>Heather</gtr:firstName><gtr:otherNames>A.</gtr:otherNames><gtr:surname>Cubie</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/60F1E169-454B-49D4-8CD2-F13ED3484A77"><gtr:id>60F1E169-454B-49D4-8CD2-F13ED3484A77</gtr:id><gtr:firstName>Sarah</gtr:firstName><gtr:otherNames>E M</gtr:otherNames><gtr:surname>Howie</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1A07ADBE-1F53-4B0F-B414-EF81C965796C"><gtr:id>1A07ADBE-1F53-4B0F-B414-EF81C965796C</gtr:id><gtr:firstName>Paddy</gtr:firstName><gtr:surname>Horner</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A58E7E60-29A0-4CA7-BF81-7788E4340366"><gtr:id>A58E7E60-29A0-4CA7-BF81-7788E4340366</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Macleod</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6D029004-264F-482F-9306-9CD1E6B8AC1B"><gtr:id>6D029004-264F-482F-9306-9CD1E6B8AC1B</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Iredale</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/21EA1447-F026-4766-BCD9-34C3B90E210E"><gtr:id>21EA1447-F026-4766-BCD9-34C3B90E210E</gtr:id><gtr:firstName>Hilary</gtr:firstName><gtr:otherNames>Octavia</gtr:otherNames><gtr:surname>Critchley</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A2DAD047-1387-40F1-91C4-F4DA43495789"><gtr:id>A2DAD047-1387-40F1-91C4-F4DA43495789</gtr:id><gtr:firstName>Sharon</gtr:firstName><gtr:surname>Cameron</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3DCAE6C3-CA04-4492-9636-E031265F488A"><gtr:id>3DCAE6C3-CA04-4492-9636-E031265F488A</gtr:id><gtr:firstName>Anna</gtr:firstName><gtr:surname>Glasier</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A7A7C5D2-2F54-40AF-9565-732358762045"><gtr:id>A7A7C5D2-2F54-40AF-9565-732358762045</gtr:id><gtr:firstName>Helen</gtr:firstName><gtr:surname>Palmer</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0800682"><gtr:id>3094B59C-4BC2-479A-9D91-78141E150803</gtr:id><gtr:title>Chlamydia trachomatis: strain distribution and host response in relation to gynaecological complications.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0800682</gtr:grantReference><gtr:abstractText>Chlamydia trachomatis is the commonest sexually transmitted infection in the UK and is estimated to cost the NHS over #100 million per year. The number of cases continues to increase in young adults. Laboratory diagnoses in Scotland for Jan-Jun 2007 show that two thirds were female with an overall 6% increase between the first and second quarters. Control measures rely on a combination of increased public awareness, diagnosis, antibiotic treatment and partner notification but are clearly failing to prevent spread of infection. C. trachomatis infection is often asymptomatic and goes untreated but can have serious implications for subsequent female reproductive health. Primary infection can resolve without intervention, presumably due to protective immunity. In some individuals C. trachomatis infection can be episodic although it is unclear whether this is due to failure of antibiotic control, bacterial persistence or to reinfection due to inadequate protective immunity in the reproductive tract. The National Chlamydia Screening Programme in England reports that 10-30% of women infected by C. trachomatis develop pelvic inflammatory disease [PID]. The risk of developing PID and other reproductive sequelae increases with each recurrence of C. trachomatis infection and infection is associated with increased risk of tubal infertility, reproductive failure and ectopic pregnancy. There is controversy as to whether some strains of C. trachomatis are more virulent than others and whether persistent infection is responsible for reproductive disease. Hitherto studies have been conducted in isolation by different groups. This disconnection has contributed to lack of clear understanding how natural history of infection and the host response translate into risk of gynaecological problems. We propose to integrate an internationally competitive, UK group of clinicians and basic scientists to investigate outcomes of C. trachomatis infection on female reproductive health.</gtr:abstractText><gtr:technicalSummary>We wish to develop a consortium of UK-wide clinicians and scientists to combine expertise and access to defined patient samples in order to investigate how sexually transmitted infection [STI] with the intracellular bacterium Chlamydia trachomatis [Ctrach] causes damage to the female reproductive tract. Ctrach is the commonest UK STI and current control measures fail to prevent spread. Infection is often asymptomatic and untreated but it can have serious implications for subsequent female reproductive health. In some individuals infection can be episodic although it is unclear whether this is due to failure of antibiotic control, bacterial persistence or to reinfection due to inadequate protective immunity. 10-30% of women infected by Ctrach develop pelvic inflammatory disease [PID] and the risk of developing PID and other reproductive sequelae [tubal infertility, reproductive failure and ectopic pregnancy] increases with each recurrence. Our hypothesis is that PID leading to tubal damage and scarring represents non-resolving inflammation triggered by C. trachomatis infection. Mutant variants and concern over development of antibiotic resistance raise the level of concern. There is no vaccine. Current therapy assumes that all strains are equally pathogenic. Through better understanding of the incidence of infection in women and their partners and of the host response in female patients who do and do not have reproductive pathology, we wish to determine whether or not all chlamydial subtypes cause similar female reproductive damage so that future therapy and prevention, including by vaccination, can be better targeted.</gtr:technicalSummary><gtr:fund><gtr:end>2008-11-18</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-02-19</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>49282</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Reproductive Health</gtr:department><gtr:description>Does Chlamydia trachomatis increase miscarriage rate?</gtr:description><gtr:id>73B36B2E-2F5A-42DD-98F0-F041C50CF976</gtr:id><gtr:impact>PhD studentship - Edinburgh Tommy's Centre Dr A Horne, Prof S Howie Prof G Entrican</gtr:impact><gtr:outcomeId>riteup1QMtu-1</gtr:outcomeId><gtr:partnerContribution>PhD supervision use of lab facilities</gtr:partnerContribution><gtr:piContribution>PhD supervision use of lab facilities</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Bristol Sexual Health Services</gtr:department><gtr:description>Does Chlamydia trachomatis increase miscarriage rate?</gtr:description><gtr:id>4B1FB415-94D5-44DC-A0A7-921866F05729</gtr:id><gtr:impact>PhD studentship - Edinburgh Tommy's Centre Dr A Horne, Prof S Howie Prof G Entrican</gtr:impact><gtr:outcomeId>riteup1QMtu-2</gtr:outcomeId><gtr:partnerContribution>PhD supervision use of lab facilities</gtr:partnerContribution><gtr:piContribution>PhD supervision use of lab facilities</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Public Lecture</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>B6FA4612-36B1-4CC2-B574-1D588EB5977F</gtr:id><gtr:impact>Lecture on the Let's Talk series run by the Centre for Reproductive Biology http://www.crb.ed.ac.uk/letstalk. &amp;quot;Pregnancy in the wrong place: causes and diagnosis of ectopic pregnancy.&amp;quot; Dr Andrew Horne and Dr Gary Entrican. Wednesday 12th November 2008 at 5.30-6.30pm. The lecture was held at Edinburgh University, the audience had to pre-register and on the day was over 350, including school students. The feedback was very positive.

School requested work placements in laboratory</gtr:impact><gtr:outcomeId>068EFDE547A</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>210818</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>&amp;quot;project grant&amp;quot;</gtr:description><gtr:end>2014-01-02</gtr:end><gtr:fundingOrg>Chief Scientist Office (CSO)</gtr:fundingOrg><gtr:id>5AC19E6C-50EF-4E02-9735-30FEB1DA5341</gtr:id><gtr:outcomeId>Bkd6GEfcd9C0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>British Fertility Society Guidelines for Practice</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3008D58B-FEC4-4ECA-8D97-CBE0A021464B</gtr:id><gtr:outcomeId>KCa767tUB2N</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Grant applications will be submitted based on the research discussions that took part - the first of these will be submitted in december 2010</gtr:description><gtr:id>B9BB4CDA-254B-441B-A1C6-4472FE31FF6B</gtr:id><gtr:impact>To be determined</gtr:impact><gtr:outcomeId>B2C073C015C</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Collaborative grant applications</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>E4E55E87-838F-47BC-B66E-92243CF2C410</gtr:id><gtr:title>av integrins on mesenchymal cells regulate skeletal and cardiac muscle fibrosis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/942000b31e6481138d8018ff5f4985d5"><gtr:id>942000b31e6481138d8018ff5f4985d5</gtr:id><gtr:otherNames>Murray IR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5aa7c7e2250a56.60390245</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DECFE1EE-7214-41C2-B909-BE45F701003F</gtr:id><gtr:title>Modelling foetal exposure to maternal smoking using hepatoblasts from pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Archives of toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/086161dc37d1dafc22f0ce3f56c5730f"><gtr:id>086161dc37d1dafc22f0ce3f56c5730f</gtr:id><gtr:otherNames>Lucendo-Villarin B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0340-5761</gtr:issn><gtr:outcomeId>5aa7c7e320b4e9.60602353</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F24057AE-B096-4489-9D54-C940A1DE27BF</gtr:id><gtr:title>The STAT3-IL-10-IL-6 Pathway Is a Novel Regulator of Macrophage Efferocytosis and Phenotypic Conversion in Sterile Liver Injury.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c43f9538db5bdad65f025ba2fd94131b"><gtr:id>c43f9538db5bdad65f025ba2fd94131b</gtr:id><gtr:otherNames>Campana L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5aa7c7e1cec772.11958479</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E312F602-3A4F-4777-BC99-A165CDED26AD</gtr:id><gtr:title>Liver Fibrosis: Understanding the Dynamics of Bidirectional Wound Repair to Inform the Design of Markers and Therapies.</gtr:title><gtr:parentPublicationTitle>Digestive diseases (Basel, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f59ad39a086828f0c6172b2bb84d8eeb"><gtr:id>f59ad39a086828f0c6172b2bb84d8eeb</gtr:id><gtr:otherNames>Iredale JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0257-2753</gtr:issn><gtr:outcomeId>5aa7c7e34ba2a8.87056286</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D730D13-4781-4C81-8A1C-A6A2160A0EC9</gtr:id><gtr:title>Impact of Chlamydia trachomatis in the reproductive setting: British Fertility Society Guidelines for practice.</gtr:title><gtr:parentPublicationTitle>Human fertility (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28f6dbf1e1505a83c7015ace113f57cf"><gtr:id>28f6dbf1e1505a83c7015ace113f57cf</gtr:id><gtr:otherNames>Akande V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1464-7273</gtr:issn><gtr:outcomeId>pm_12488_28_20849196</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31702A58-F87D-4735-B115-0A5E13E5F182</gtr:id><gtr:title>BREXIT and science, where do we go from here.</gtr:title><gtr:parentPublicationTitle>QJM : monthly journal of the Association of Physicians</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f59ad39a086828f0c6172b2bb84d8eeb"><gtr:id>f59ad39a086828f0c6172b2bb84d8eeb</gtr:id><gtr:otherNames>Iredale JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1460-2393</gtr:issn><gtr:outcomeId>5aa7c7e38cfb85.21872205</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A439E19-093D-4D18-84AE-2DD38E549B19</gtr:id><gtr:title>Detecting drug-target binding in cells using fluorescence-activated cell sorting coupled with mass spectrometry analysis.</gtr:title><gtr:parentPublicationTitle>Methods and applications in fluorescence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/351bdc8c8becb59d14adc9d737744c16"><gtr:id>351bdc8c8becb59d14adc9d737744c16</gtr:id><gtr:otherNames>Wilson K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2050-6120</gtr:issn><gtr:outcomeId>5aa7c7e2c56306.73994314</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA4E6D97-651A-4C94-B7B9-7F532C5AB60D</gtr:id><gtr:title>In search of a small molecule agonist of the relaxin receptor RXFP1 for the treatment of liver fibrosis.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe850fd2185775a32e2d3114aa1f4703"><gtr:id>fe850fd2185775a32e2d3114aa1f4703</gtr:id><gtr:otherNames>McBride A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5aa7c7e2e59606.12363839</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9181323C-2823-4371-8DA4-EAAFADBAAF46</gtr:id><gtr:title>Sex differences in the relationship between heavy alcohol use, inhibition and performance monitoring: Disconnect between behavioural and brain functional measures.</gtr:title><gtr:parentPublicationTitle>Psychiatry research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a21e8fce953504093027a338b386bea"><gtr:id>3a21e8fce953504093027a338b386bea</gtr:id><gtr:otherNames>Smith JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0165-1781</gtr:issn><gtr:outcomeId>5aa7c7e3aa4ad8.20302296</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B983EB0-2210-4185-BE9E-90D9CA79C91D</gtr:id><gtr:title>11Beta-hydroxysteroid dehydrogenase-1 deficiency or inhibition enhances hepatic myofibroblast activation in murine liver fibrosis.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/323327f946161a4d54706803fcf93469"><gtr:id>323327f946161a4d54706803fcf93469</gtr:id><gtr:otherNames>Zou X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>5aa7c7e20525a1.66703524</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>117AF692-3C42-4C4A-93D5-A20040236C3B</gtr:id><gtr:title>Chlamydia trachomatis infection during pregnancy: known unknowns.</gtr:title><gtr:parentPublicationTitle>Discovery medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/133c60033b8613f49c41cc70c6fbdc22"><gtr:id>133c60033b8613f49c41cc70c6fbdc22</gtr:id><gtr:otherNames>Howie SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1539-6509</gtr:issn><gtr:outcomeId>pm_12488_28_21794209</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1C69EA1-3632-4CD9-98BD-6843031D3393</gtr:id><gtr:title>MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64f42b266fd11aa87e2c88a384ee9d26"><gtr:id>64f42b266fd11aa87e2c88a384ee9d26</gtr:id><gtr:otherNames>Ho GT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>5aa7c7e36af2d9.54753624</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800682</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>